Servier is a pharma company governed by a non-profit foundation
Welcome to the Servier website.
Use the search field to explore our articles and resources.
Our latest news
- Therapeutic adherence at the forefront of the new #BecauseISaySo campaign 2 September 2026 Link
- Understanding clinical trials 28 August 2026 Link
- Sarah’s story, Senior Clinical Operations Project Manager, Australia 27 August 2026 Link
- Paula’s story, Medical Representative, Colombia 27 August 2026 Link
- Élodie’s story, Organic & Medicinal Chemistry Technician, France 27 August 2026 Link
- Qiang’s story, QC Engineer, China 27 August 2026 Link
- How can we minimize the environmental footprint of a medicine without compromising its quality or safety? 17 August 2026 Link
- #LegsFirst: Servier committed to make leg health a daily priority 6 August 2026 Link
- Patient Voices: Caregiving, a full-time commitment 22 July 2026 Link
- Oncology innovation gains momentum in Japan 17 July 2026 Link
- Servier completes the acquisition of Edgewise Therapeutics’ Muscular Dystrophy Business 13 July 2026 Link
- Venous disease: when the circulatory system is affected 9 July 2026 Link
- One Job, Many Stories: celebrating women engineers across Servier Industry! 23 June 2026 Link
- Seedpods Day: Honoring Servier’s junior researchers at Paris-Saclay 17 June 2026 Link
- Servier x L’ADN: More complex, more open: innovation as an archipelago 12 June 2026 Link
- Servier and n-Lorem Foundation join forces to advance research in rare neurodevelopmental disorders 10 June 2026 Link
- Servier joins the United Nations Global Compact: A milestone for our sustainability commitment 9 June 2026 Link
- Servier to Acquire Edgewise Therapeutics’ Muscular Dystrophy Business 1 June 2026 Link
Our solutions for patients
Three key therapeutic areas
Involving patients enables us to design suitable therapeutic solutions in each of our three therapeutic areas.
Cancers
A focused and innovative player developing targeted therapies to treat cancer
Cardio metabolism
Over 70 years of unwavering commitment in cardiometabolism and venous diseases
Neurology
Addressing major medical needs in rare neurological disorders
Colorectal cancer: Screening still comes too late
Colorectal cancer is a common disease. It is one of the most frequently diagnosed cancers in the world – ranking third behind lung cancer and liver cancer – and it affects almost as many women as men. Read more
Cholangiocarcinoma, a rare tumor of the bile duct
The malignant tumors in cholangiocarcinoma, a type of cancer of the bile duct, are rare and aggressive. Read more
Glioma: a rare, aggressive brain tumor
Glioma is the most common primary brain tumor in adults. Read more